Tapentadol Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 5 USDMF, 3 CEP/COS, 6 EU WC, 2 KDMF, 5 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

216 FDF Dossiers, 30 FDA Orange Book, 115 Europe, 8 Canada, 5 Australia, 5 South Africa, 53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 250MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE, SOLUTION;ORAL - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 3 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

53 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 31 Controlled & Modified Release, 25 Direct Compression, 18 Granulation, 18 Disintegrants & Superdisintegrants, 17 Thickeners and Stabilizers, 14 Solubilizers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 11 Topical, 10 Film Formers & Plasticizers, 7 Parenteral, 6 Taste Masking, 5 Empty Capsules, 5 Coloring Agents, 4 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids

DIGITAL CONTENT

30 NEWS #PharmaBuzz

30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 93 Finished Drug Prices

MARKET PLACE

26 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

53 US Patents, 8 US Exclusivities, 56 Health Canada Patents

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 200533 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
tapentadol hydrochloride(UNII: 71204KII53) (tapentadol - UNII:H8A007M585)	tapentadol	100mg

Inactive Ingredients

Ingredient Name	Janssen Pharmaceuticals, Inc.	Lake Erie Medical DBA Quality Care Products LLC	LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC
.ALPHA.-TOCOPHEROL(H4N855PNZ1)
ALUMINUM OXIDE(LMI26O6933)
FD&C BLUE NO. 2(L06K8R7DQK)
ferric oxide yellow(EX438O2MRT)
ferrosoferric oxide(XM0M87F357)
HYPROMELLOSE, UNSPECIFIED (3NXW29V3WO)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
hypromelloses(3NXW29V3WO)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
polyethylene glycols(3WJQ0SDW1A)
polyvinyl alcohol(532B59J990)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
PROPYLENE GLYCOL (6DC9Q167V3)
propylene glycol(6DC9Q167V3)
SHELLAC (46N107B71O)
SHELLAC(46N107B71O)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE (15FIX9V2JP)
titanium dioxide(15FIX9V2JP)

Drug Product Composition: Tapentadol Hydrochloride